Hospitals and health systems across the nation are among thousands of healthcare facilities participating in the Drug Enforcement Agency's National Prescription Drug Take Back Day on Oct. 28. 

A combined phase 1 and 2 clinical trial of Pfizer's mRNA flu and COVID-19 combination vaccine have yielded positive results, the company announced Oct. 26.

A growing pile of research is finding a positive correlation between vaccinations and a reduced risk of Alzheimer's disease and related dementias, The Washington Post reported Oct. 26. 

Most "close calls" of medication errors are not analyzed because most organizations manually review mistakes that lead to patient harm. Researchers at Columbia, Md.-based MedStar Health used machine learning to fix this lack of insight. 

Exela Pharma Sciences is pulling three medications, including one Civica brand, because silicone was found in samples during routine inspection, the FDA said Oct. 25. 

The risk of a stroke was more prevalent for older adults who received a flu and bivalent COVID-19 vaccine within six weeks of the other in fall 2022, according to a preprint of research conducted by the FDA and CMS. 

Monthslong drug shortages have affected quality in surgery, emergency care and other hospital departments in 2023, according to a recent survey of 200 healthcare workers. Recently, eight more medications have fallen into short supply or discontinuation. 

A three-hospital system in Oswego, N.Y., filled its pharmacy director position with Sarah Driscoll, PharmD, who has been in the role in an interim capacity since June. 

Sen. Bernie Sanders, I-Vt., is urging HHS to investigate the National Institutes of Health's proposal to grant an exclusive patent to a cancer drug that NIH invented, manufactured and tested. 

Lexington, Ky.-based Appalachian Regional Healthcare has promoted Colby Newsome, PharmD, to director of its Behavioral Health Pharmacy.